Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Technology
Vandana Singh

Eli Lilly To Suspend Sale Of 'Non-Essential' Medicines To Russia

  • Eli Lilly And Co (NYSE:LLY) said it would continue to supply drugs to Russia for urgent medical conditions such as cancer and diabetes but will suspend sales of "non-essential medicines."
  • Lilly also suspended investments and promotion activities in Russia and will not start any new clinical trials in the country.
  • With several Western companies leaving Russia, drugmakers and medical-device firms have also said they will stop investments and new clinical trials in the country but will continue to provide medicines to patients for humanitarian reasons.
  • As per Reuters, Lilly is the first to exclude drugs it designates as "non-essential," It did not disclose specific treatments affected by the decision.
  • On Monday, Pfizer Inc (NYSE:PFE), Bayer AG (OTC:BAYRY), and Abbott Laboratories (NYSE:ABT) said that they have pulled back from non-essential spending in Russia. 
  • Related: Pfizer To Stop New Clinical Trials In Russia: Reuters.
  • Lilly said any profit from continued sales in Russia would be donated to organizations dedicated to humanitarian relief.
  • Price Action: LLY shares are up 2.44% at $275.58 during the market session on the last check Tuesday.
Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.